跳至主要内容
临床试验/ISRCTN06890529
ISRCTN06890529已完成未知

A randomised study about the effect on survival of hormonal therapy versus hormonal therapy plus local external radiation therapy in patients with primary diagnosed metastasised (M+) prostate cancer

Onze Lieve Vrouwe Gasthuis (OLVG) (The Netherlands)0 个研究点目标入组 425 人开始时间: 2005年12月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
425

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. Histologically proven adenocarcinoma of the prostate
  • 2. Stage T1-4, G1-3, N0-2, M1
  • 3. Bone metastases diagnosed with a bonescan

排除标准

  • 1. Start therapy more than 8 weeks after the initial diagnoses
  • 2. Other treatment for prostate cancer before start of the study therapy
  • 3. Other malignancies except skin carcinoma
  • 4. Prostate specific antigen (PSA) less than 20 ng/ml
  • 5. Aged greater than 80 years
  • 6. Participation in another protocol
  • 7. Not capable of filling out quality of life questionnaires

研究者

发起方
Onze Lieve Vrouwe Gasthuis (OLVG) (The Netherlands)

相似试验